Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy.
Saved in:
| Title: | Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy. |
|---|---|
| Authors: | Alijanzadeh D; Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Moghim S; Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran., Zarand P; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Akbarzadeh MA; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Zarinfar Y; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Khaheshi I; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. isa_khaheshi@yahoo.com. |
| Source: | Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2025 Dec; Vol. 39 (6), pp. 1567-1584. Date of Electronic Publication: 2024 Dec 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7241 |
|---|---|
| DOI: | 10.1007/s10557-024-07652-3 |
